RE:Acquisitions
Roll Up companies can often get themselves into trouble (see Nobilis Health, PHM, etc.). I would be cautious about a company that does too many acquistions too quickly as they may be purchasing interest in businesses that are of inferior quality to those purchased previously. Also, one must weigh the cost of acquisition plus ongoing expenses vs. the portion of the profits CRH will actually earn for shareholders.
CRH is still a good story in my view, but slow and steady is the way to go in my view. As mentioned in my earlier posts, I think the stock was signficantly overpriced at $12.00+ and management would have been wise to issue an equity offering at that time to cash in on the high share price.....